首页 › 基金 › ADAR1 Capital Management, LLC › ZURA

ADAR1 Capital Management, LLC 对 ZURA 的持仓历史

ZURA BIO · 医疗保健

ADAR1 Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 ZURA(ZURA BIO)1,759,295 股,市值约 US$10.4M,约占其申报组合的 0.57%,在其申报持仓中市值排名第 48 位。 ADAR1 Capital Management, LLC 最近 8 个申报季度中有 8 个季度披露了 ZURA 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q2 2026)1.76M 股
申报持仓市值$10.38M
组合权重0.57%
首次申报Q3 2024
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

ADAR1 Capital Management, LLC 对 ZURA 的持仓演变

ADAR1 Capital Management, LLC 于 Q3 2024 首次披露 ZURA 持仓:3,770,649 股(约 US$15.3M)。 在 8 次申报中,ADAR1 Capital Management, LLC 3 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,759,295 股、市值约 US$10.4M,环比增持 1,128,892 股。。 持仓曾出现大幅变动:Q4 2024 减持约 45% (随后一个季度股价下跌 48%)、Q2 2025 减持约 64% (随后一个季度股价上涨 312%)、Q2 2026 增持约 179% (随后一个季度股价下跌 29%)。

逐季持仓明细

季度股数金额变化
Q3 2024 3.77M $15.31M 新进
Q4 2024 2.08M $5.19M 减持
Q1 2025 2.80M $3.61M 增持
Q2 2025 997.55K $1.05M 减持
Q3 2025 652.15K $2.82M 减持
Q4 2025 562.07K $2.95M 减持
Q1 2026 630.40K $3.75M 增持
Q2 2026 1.76M $10.38M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ZURA 与 13F 数据

ZURA(ZURA BIO)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 ZURA,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ZURA 的基金

查看 ZURA 的全部基金持有人 →

常见问题

How long has ADAR1 Capital Management, LLC held ZURA?

ADAR1 Capital Management, LLC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is ADAR1 Capital Management, LLC's current position in ZURA?

As of Q2 2026, ADAR1 Capital Management, LLC holds 1.76M shares of ZURA (ZURA BIO), valued at $10.38M, representing 0.57% of its reported portfolio and ranking #48.

Has ADAR1 Capital Management, LLC been buying or selling ZURA?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ZURA.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.